» Articles » PMID: 29744179

Lack of Adjunctive Effect of 0.1% Sodium Hypochlorite Mouthwash Combined to Full-mouth Ultrasonic Debridement on Supragingival Plaque, Gingival Inflammation, and Subgingival Microbiota: A Randomized Placebo-controlled 6-month Trial

Overview
Publisher Wiley
Specialty Dentistry
Date 2018 May 11
PMID 29744179
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

To test the adjunctive effect of 0.1% sodium hypochlorite (NaOCl) mouthwash combined to full-mouth ultrasonic debridement (FMUD) on reducing supragingival plaque, gingival inflammation, and microbial pathogens. In this 6-month double-blinded randomized clinical trial, individuals with gingivitis were assigned to test ( = 16) or placebo group ( = 16) and received FMUD followed by rinsing with 0.1% NaOCl (test) or distilled water (placebo), respectively, twice a day for 1 month. Full-mouth periodontal examination was performed at baseline, 1, 3, and 6 months posttherapy, and subgingival plaque samples were obtained at the same time points and analysed for their composition by checkerboard. Differences between groups over time were examined by Student test, Mann-Whitney, generalized linear model, and Friedman and chi-square tests. Both therapeutic protocols resulted in significant clinical improvement in periodontal parameters over time, except for probing depth and attachment level, which had a slight mean increase of 0.2 mm ( < .01). No significant differences between groups were observed for any clinical parameter ( > .05). Most species (>65%) decreased similarly in levels in both groups over time. Significant reductions in the microbial complexes were seen mainly at 1 and 3 months, but they returned to baseline levels in both groups, except for the red and yellow complexes, and other oral species, which were kept in low levels at 6 months ( < .05). A 0.1% NaOCl mouthwash did not provide additional benefits to FMUD in reducing supragingival plaque, gingivitis, and/or microbial pathogens.

Citing Articles

Three-Dimensional Planimetry Assessment of Dental Plaque-Covered Area Reduction after Rinsing with 0.2% Sodium Hypochlorite Solution as Part of a Guided Biofilm Therapy Protocol-Pilot Longitudinal Study.

Kardaras G, Boariu M, Varlamov V, Vintila C, Boia S, Belova A Biomedicines. 2024; 12(10).

PMID: 39457638 PMC: 11504904. DOI: 10.3390/biomedicines12102326.


A Low-Cost Protocol Using the Adjunctive Action of Povidone-Iodine Irrigations and Sodium Hypochlorite Rinsing Solution in Step 2 of Periodontal Therapy for Patients with Stage III-IV Periodontitis: A Single-Blind, Randomized Controlled Trial.

Kardaras G, Christodorescu R, Boariu M, Rusu D, Belova A, Chinnici S Dent J (Basel). 2024; 12(5).

PMID: 38786542 PMC: 11119210. DOI: 10.3390/dj12050144.


In-Vitro Safety Evaluation of Sodium Hypochlorite (NaOCl) as Part of Step 2 and Maintenance Therapy Protocols in Patients with Periodontitis Stages III-IV.

Kardaras G, Marcovici I, Rusu D, Dehelean C, Coricovac D, Iorio-Siciliano V Oral Health Prev Dent. 2023; 21:103-112.

PMID: 37014214 PMC: 11577687. DOI: 10.3290/j.ohpd.b4009557.


Effect of a sodium hypochlorite mouthwash on plaque and clinical parameters of periodontal disease-a systematic review.

Hussain A, Van der Weijden G, Slot D Int J Dent Hyg. 2021; 20(1):40-52.

PMID: 33971082 PMC: 9292655. DOI: 10.1111/idh.12510.


Lack of adjunctive effect of 0.1% sodium hypochlorite mouthwash combined to full-mouth ultrasonic debridement on supragingival plaque, gingival inflammation, and subgingival microbiota: A randomized placebo-controlled 6-month trial.

Espindola L, Colombo A Clin Exp Dent Res. 2018; 3(2):51-61.

PMID: 29744179 PMC: 5719817. DOI: 10.1002/cre2.60.

References
1.
Hujoel P, Cunha-Cruz J, Loesche W, Robertson P . Personal oral hygiene and chronic periodontitis: a systematic review. Periodontol 2000. 2005; 37:29-34. DOI: 10.1111/j.1600-0757.2004.03795.x. View

2.
Galvan M, Gonzalez S, Cohen C, Alonaizan F, Chen C, Rich S . Periodontal effects of 0.25% sodium hypochlorite twice-weekly oral rinse. A pilot study. J Periodontal Res. 2013; 49(6):696-702. DOI: 10.1111/jre.12151. View

3.
Baehni P, Takeuchi Y . Anti-plaque agents in the prevention of biofilm-associated oral diseases. Oral Dis. 2003; 9 Suppl 1:23-9. DOI: 10.1034/j.1601-0825.9.s1.5.x. View

4.
Addy M . Oral hygiene products: potential for harm to oral and systemic health?. Periodontol 2000. 2008; 48:54-65. DOI: 10.1111/j.1600-0757.2008.00253.x. View

5.
Cho I, Blaser M . The human microbiome: at the interface of health and disease. Nat Rev Genet. 2012; 13(4):260-70. PMC: 3418802. DOI: 10.1038/nrg3182. View